SCHEMBL11019595

SCHEMBL11019595

O=C1c2ccccc2C(=O)N1CCCOc1ccccc1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.67
MAPT P10636 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
NPC1 O15118 1/20 0.57
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.57
ALDH1A1 P00352 8/20 0.57
HTT P42858 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
KDM4E B2RXH2 5/20 0.56
PKM P14618 1/20 0.56
USP2 O75604 1/20 0.53
TP53 P04637 2/20 0.53
MAPK1 P28482 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
POLB P06746 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10525636 0.95 RAB9A (0.60) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL10527602 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11022117 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11022440 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11021192 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL10527237 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11019210 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11017799 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11023145 0.94 RAB9A (0.59) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL11021376 0.91 RAB9A (0.56) RAB9AMAPTSMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 EP disclosed